PYREXIA is the #6 most commonly reported adverse reaction for DOXORUBICIN HYDROCHLORIDE, manufactured by Baxter Healthcare Company. There are 1,731 FDA adverse event reports linking DOXORUBICIN HYDROCHLORIDE to PYREXIA. This represents approximately 2.7% of all 64,420 adverse event reports for this drug.
Patients taking DOXORUBICIN HYDROCHLORIDE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
PYREXIA1,731 of 64,420 reports
PYREXIA is a less commonly reported adverse event for DOXORUBICIN HYDROCHLORIDE, but still significant enough to appear in the safety profile.
Other Side Effects of DOXORUBICIN HYDROCHLORIDE
In addition to pyrexia, the following adverse reactions have been reported for DOXORUBICIN HYDROCHLORIDE:
PYREXIA has been reported as an adverse event in 1,731 FDA reports for DOXORUBICIN HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is PYREXIA with DOXORUBICIN HYDROCHLORIDE?
PYREXIA accounts for approximately 2.7% of all adverse event reports for DOXORUBICIN HYDROCHLORIDE, making it a notable side effect.
What should I do if I experience PYREXIA while taking DOXORUBICIN HYDROCHLORIDE?
If you experience pyrexia while taking DOXORUBICIN HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.